1 minute read
Development Of The Plan
DEVELOPMENT OF THE STRATEGY
Our original Breakthrough Cancer Research strategy was developed from the vision of our founder the late Professor Gerry O’Sullivan and continued following his passing in 2012. Following a ten year period of delivering that strategy, we updated and developed our new research strategy, through a comprehensive review of all Breakthrough-funded research, outputs, policies, processes, grants programmes (internal and external), and internal resources/ capacity, in tandem with a review of the National Cancer Strategy and research funding landscape was undertaken. The Board, our International Scientific Advisory Committee and Executive and Public Patient Involvement Panel worked closely to review and revise our research strategy to set out a new five year plan (2022- 2027) to expand and build on the considerable impact of the charity to date and to strive for even greater improvement in the survival of poorer prognosis cancers through research. Extensive stakeholder consultation was conducted including, but not limited to, researchers, clinicians, allied health professionals, patients, survivors and family members nationally and internationally.
CONSULTING WITH OUR SCIENTIFIC ADVISORY COMMITTEE AND PUBLIC PATIENT INVOLVEMENT PANEL BREAKTHROUGH CANCER RESEARCH STRATEGY
